You searched for "retinal"

3393 results found

Nikolaos Koutris takes on half marathon to raise awareness for Sight Scotland and high eye pressure

Nikolaos Koutris, 37, originally from Greece and now residing in Edinburgh, has been inspired to run a half marathon for Sight Scotland after being diagnosed with high eye pressure.

Orbis UK release 2024 highlights video

Orbis UK have released their 2024 highlights video, revealing some of the incredible achievements their supporters helped make possible last year. The Orbis Flying Eye Hospital completed two sight-saving missions to Mongolia and Bangladesh. Orbis's clinical staff and Volunteer medical...

Glaucoma UK introduces its first ever Pitts Crick Fellow

Glaucoma UK is delighted to announce the recipient of their first ever Pitts Crick Fellowship. This Fellowship was an important part of the charity’s 50th anniversary celebration throughout 2024. Its aim was to honour the legacy of the founder Ronald...

Newmedica calls for transparency over glaucoma waiting lists and more collaboration with community optometrists

Ophthalmology provider Newmedica is calling for greater transparency by all providers over glaucoma waiting lists to tackle a ‘postcode lottery’ facing patients. Coinciding with Glaucoma Awareness Week (30 June – 6 July), Newmedica, which provides NHS and private ophthalmology services,...

50 Studies Every Ophthalmologist Should Know

This book features a compilation of 50 important clinical studies that have left a profound impact on the current clinical practice of ophthalmology. From the 1980 botulinum toxin injection study by AB Scott to the United Kingdom Glaucoma Treatment Study...

IVTA use in Behçet’s disease

This study aimed to evaluate the efficacy and safety of intravitreal triamcinolone acetonide (IVTA) injection (4mg/0.1ml) in controlling posterior segment inflammation in patients with Behçet’s disease. Medical records of consecutive patients diagnosed with Behçet’s who underwent IVTA between July 2005...

A comparative evaluation of a new diffractive trifocal and EDOF IOLs

This study aimed to compare the outcomes of two diffractive trifocal intraocular lenses and one extended depth of focus (EDOF) intraocular lens (IOLs). This was a six month, single centred, prospective, randomised, comparative study in which patients who underwent routine...

Corneal cross-linking for treatment of corneal ulcers

This was an observational cohort study looking at the usefulness of photo activated chromophore for infectious keratitis-corneal collagen cross-linking (PACK-CXL) in reducing the time to heal in suppurative corneal ulcers. This study, conducted in a tertiary care centre in South...

Evisceration in India: demographic and clinical trends from a large multicentre cohort study

In this multicentre cohort study, the authors investigated a total of 2071 patients who underwent evisceration with primary implant placement over a six-year period at four tertiary eyecare centres in India. Out of 1,345,480 new ophthalmic presentations during the study...

Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system

Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...

Haag-Streit UK to offer iTrack Advance ‘Meet the experts’ sessions at UKEGS 2024

Haag-Streit UK will be exhibiting as a gold sponsor at the United Kingdom & Eire Glaucoma Society (UKEGS) event in Southampton on the 9th and 10th October 2024, where they will be showcasing the iTrack Advance microcatheter. Delegates will have...

HASA OPTIX Certifies as a B Corporation

Premium recyclable ophthalmic instrument company HASA OPTIX announces its certification as a B Corporation (B Corp) company. In a press release, the Brussels-based scale-up confirmed its score of 109.7 points on the B Impact Assessment, in which nonprofit B Lab...